NCT06757335 2025-01-03A Phase I/II Trial to Evaluate Oral HP568 Tablets in Patients with ER+/HER2 Advanced Breast CancerHinova Pharmaceuticals Inc.Phase 1/2 Not yet recruiting204 enrolled